MTNB Stock Summary and Trading Ideas (Matinas Biopharma Hldgs | AMEX:MTNB)

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Matinas Biopharma Hldgs trades on the AMEX stock market under the symbol MTNB.

As of August 19, 2026, MTNB stock price climbed to $0.21 with 784,240 million shares trading.

MTNB has a beta of 2.26, meaning it tends to be more sensitive to market movements. MTNB has a correlation of 0.04 to the broad based SPY ETF.

MTNB has a market cap of $3.09 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, MTNB traded as high as $4.49 and as low as $.09.

The top ETF exchange traded funds that MTNB belongs to (by Net Assets): VXF.

MTNB has underperformed the market in the last year with a price return of -87.7% while the SPY ETF gained +20.8%. MTNB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -61.1% and -27.7%, respectively, while the SPY returned +4.5% and -0.2%, respectively.

MTNB support price is $.19 and resistance is $.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MTNB shares will trade within this expected range on the day.